Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
With funds only available for 3 more years and nothing as significant as CLI was from a market potential perspective in the near future, it’s very disheartening from an investment perspective. I would love to see this company succeed. Perhaps if they could leverage their manufacturing capabilities with other companies, it could provide an alternate revenue stream for them. They have to start making revenue now.
Big time buy opportunity!
I hope that data is true.
Any you’re buying the snake oil being sold by an aspiring dictator. Good luck with that.
The CDC’s credibility, unfortunately, has taken taken it on the chin due to political interference.
Anyway, according to the CDC, the COVID death count is now 201,411. In comparison, in 2018-2019, there were 34,200 deaths from the flu.
There is no evidence that, in the US, the flu kills more than 200k in 6 months, regardless of age. Is there data that shows that?
Interesting, I’m curious if the CDC believes the flu would have killed that many people with at least (2) serious conditions. If COVID-19 tipped the scales and led to the deaths of those with a pre-existing conditions then I can understand how the numbers are 200k in the US.
In any case, many lives have been lost in a very short period of time. I am really hopeful that Pluristem’s therapeutics can save lives.
Question: In the US, is a typical mortality rate for the flu 200k in (6) months?
IMO...If you’ve lost confidence go ahead sell your shares and move on.
The rest of us who believe PSTI will be a difference maker in therapeutics and benefit the world will hang tight.
No doubt about it, this is a high risk, high reward investment. I’m confident Pluristem’s therapeutics are the future of medicine.
Agreed!
Adding 30m shares based on current market cap and outstanding shares has PPS much lower.
Many of you know but for those that don’t, here are the major players in the global stem cell market:
Pluristem Therapeutics
Ocata Therapeutics
Opexa Therapeutics
Teva Pharmaceuticals
CHA Bio & Diostech
United Therapeutics
Nuo Therapeutics
Mesoblast
Athersys
Osiris Therapeutics
Caladrius Biosciences
Celgene
Cytori Therapeutics
News such as the steroid dexamethasone comes out and fear sets in that Pluristem relevant for COVID-19 cases. Rest easy, Pluristem is and will be relevant. It’s a regenerative therapeutic from a organic source. As cases of COVID-19 increase, the recruitment for the clinical trial should fill up very soon!
Here’s a link to the trial details.
Brief Summary:
This clinical trial will examine if a new treatment of Mesenchymal Stems Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.
https://clinicaltrials.gov/ct2/show/NCT04389450?term=Pluristem&draw=2&rank=1
I agree completely. Unfortunately, we’re dealing with a pandemic. Fortunately, we’re invested in a company that will save many many lives! I’m all in on PSTI.
The current market does not reflect the uncertainty that surrounds us all: pandemic (COVID-19), record joblessness, civil unrest, and political turmoil. IMO, It is highly probable that another market crash will occur. There are several analysts beginning to say the same thing and it is unnerving.
PSTI is addressing one of these uncertainties; if I catch COVID-19, will I survive? There is evidence that PLX-PAD, a Pluristem therapeutic, will save lives. It already has! There are also other therapeutics in the pipeline that have enormous potential throughout the world. PSTI, IMO, is smart investment during these uncertain times. The growth potential is tremendous!
https://www.cnbc.com/2020/06/10/stock-market-rally-has-created-a-dangerous-environment-ceo.html?__source=facebook%7Cmain
The manipulators know something big is coming!
The realization that COVID-19 has not gone away is now impacting the the markets. The pressure to abandon PSTI to get in the game of pursuing rising stocks other industries was high! It takes nerves of steel and a true belief in what Pluristem is doing to hang tight and stick it out. IMHO, its going to payoff!
There’s a lot of perspectives being offered on this message board and that’s awesome! I really appreciate the effort many of you put in to find valuable content. Keep up the food work!!! Go PSTI!!!
The 2nd wave of COCID-19, unfortunately, is on our doorstep. The evidence is clear by the rising numbers throughout the US and across the globe. If your invested in PSTI, you’re wise. As focus returns to battling this terrible virus, investors will see PSTI as the true leader and innovator in stem cell therapeutics. The PPS is moving up slowly. IMO, this is a $100 stock when validated through clinical trials.
Way to load up! That’s a fantastic price for where we’ll end up!
Creeping up slowly. Waiting on that BIG NEWS! Where is it?
PSTI continues to be a great buying opportunity. It’s going to sky rocket when the second wave hits and lives will be saved. The rest of the market, IMO, will hit a new bottom before the end of the year. COVID-19 case are increasing each day. This isn’t over folks. Stay strong with PSTI. It will payoff!
Thanks for sharing. Hang in there everyone. This is the future of medicine!
I enjoy your positivity! I’m with ya!
XOV,
That article was written by Asma UL Husna from Insider Monkey. Her work can be found on Yahoo Finance, Yahoo, Insider Monkey, and The Journal of Biological Chemistry.
The relevance of the article to my post is how hedge funds have significantly increased their position in PSTI.
About the author:
https://www.insidermonkey.com/authors/
Thanks for pointing out the Yahoo article, it reinforces my suspicions.
IMO, If you look objectively at Pluristem, it has all of the attributes of a breakout company. The demand for their therapeutics are in high demand, they have a proven safety profile, and they’re scalable from a manufacturing and distribution perspective. They are READY to go to market immediately after clinical trials end and prove successful, and they will be successful! The large investors know it which is why they are buying up significant amounts of shares each week. They know something is coming coming and it’s going to be big!
IMO, There is no reason why PSTI shares shouldn’t be trading much higher right now. The fact that shares remain low and big investors are consistently increasing their position in PSTI each week is a strong signal that the stock is going somewhere! I’m extremely Bullish on PSTI. It going to make a lot of believers in them very wealthy!!!
Here’s a like to the article describing Hedge funds keeping PSTI’s price low:
https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/hedge-funds-nibbling-pluristem-therapeutics-200532621.html
I see airline stocks going up. But I really feel that it is based on a false sense that we are out of this pandemic. The government’s silence and lack of response is give a false sense of security.
It amazes me that Pluristem, with its innovation and potential doesn’t go above $10 and stay. IMO, I think this stock is highly manipulated to keep the price low to allow big investors to keep buying. IMO they know this is going to be a BIG win and they know big news is coming down the road.
Regardless, it feels like I’m missing out on other opportunities waiting on PSTI. However, I’m hanging in there though. I do believe in the company!
That’s right. Unfortunate.
Still waiting on Russell 2000 additions.
https://www.ftserussell.com/resources/russell-reconstitution
We investors are in this together! I truly hope everyone here accomplishes their financial objectives through the success of Pluristem. They have a real shot at becoming a multi-billion dollar company that can benefit the lives of millions of patients around the globe.
I personally appreciate all of the valuable content and perspective many of you provide in this forum. I know a lot of effort goes into your posts. Keep up the good work!
When Pluristem hits $100 per share we should have a virtual celebration! Cheers to all!!!
We investors are in this together! I truly hope everyone here accomplishes their financial objectives through the success of Pluristem. They have a real shot at becoming a multi-billion dollar company that can benefit the lives of millions of patients around the globe.
I personally appreciate all of the valuable content and perspective many of you provide in this forum. I know a lot of effort goes into your posts. Keep up the good work!
When Pluristem hits $100 per share we should have a virtual celebration! Cheers to all!!!
Thanks for the update. I’ll be tuned in!
I hope everyone took advantage of the low PPS. It’s still a great time to get in. PSTI is going to soar! IMO, this is the Apple of Biotech. Investors are going to get rich with this Company!!!
It’s exciting to be invested in a company that can save lives. What an impact they will have!
I think you’re right!
I think you’re right-on with that assessment!
This pandemic is not over by any means. The day’s stock price does not change that fact. Some historical perspective to keep in mind...
“There were 3 different waves of illness during the pandemic, starting in March 1918 and subsiding by summer of 1919. The pandemic peaked in the U.S. during the second wave, in the fall of 1918. This highly fatal second wave was responsible for most of the U.S. deaths attributed to the pandemic.
A third wave of illness occurred during the winter and spring of 1919, adding to the pandemic death toll. The third wave of the pandemic subsided during the summer of 1919.”
“An estimated 1/3 of the world’s population was infected with the 1918 flu virus – resulting in at least 50 million deaths worldwide.”
- source: https://www.cdc.gov/flu/pandemic-resources/1918-commemoration/three-waves.htm
100,000 deaths in approx. 2.5 months in the US. It’s not smart to to relax interest on this. Look at the history of the Spanish Flu. The second wave was most devastating.
Just loaded up at $7.89. This is a great buying opportunity to get in on a company that is going to be a big impact on our future.
The immediate concern is COVID-19 and it isn’t going away anytime soon and we need a scalable solution to save critically ill patients now. Just look at the entire product line any as an investor you can that see the potential upside is incredibly significant!
Are we looking at $100 per share once this therapeutics machine gets rolling? What do you think? On a global scale, in my opinion that is a low estimate.
There is no doubt in my mind that a second wave of COVID-19 is coming, in fact it may be here already. A solution for critical patients is needed and Pluristem’s PLX-PAD appears to be the most scalable. Not to mention the other therapeutics in PSTI’s pipeline.
Assuming clinical trials go well and PLX-PAD is adopted as a viable treatment for critical patients with ARDS. What is a realistic market cap and how high could PSTI’s stock go? Assuming a dilution does not occur.
VOTE NO to more shares!
The powers that be are moving this stock significantly lower. Great buy opportunity. Is this a setup for a breakout next week? News should be coming soon. Long’s hang in there. PSTI is a game changer in the Biotech space.